Management of skin disease in lupus

Bulletin on the Rheumatic Diseases

Volumn 46, Issue 2, 1997, Pages 4-7

  Callen, Jeffrey R ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AURANOFIN; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOKINE; CYTOTOXIC AGENT; ETRETINATE; ISOTRETINOIN; LEPROSTATIC AGENT; METHOTREXATE; OKT 4; PHENYTOIN; RETINOIC ACID; RETINOID; SUNSCREEN;

CORTICOSTEROID THERAPY; DRUG CHOICE; HUMAN; REVIEW; SKIN LUPUS ERYTHEMATOSUS; SKIN SURGERY; TOPICAL DRUG ADMINISTRATION; TREATMENT INDICATION; TREATMENT PLANNING;

ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, DISCOID; STEROIDS; SUNSCREENING AGENTS;

EID: 0030935021     PISSN: 00075248     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Callen JP: Treatment of cutaneous lesions in patients with lupus erythematosus. Dermatol Clin 12:201-206, 1994.
2. Callen JP, Spencer LV, Burruss JB, Holtman J: Azathioprine: an effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol 127:515-522, 1991.
3. Piette JC, Frances C, Roy S, et al: High-dose iminunoglobulins in the treatment of refractory cutaneous lupus erythematosus. Open trial in 5 cases [abstract]. Arthritis Rheum 38:S304, 1995.
4. Holtman J, Neustadt D, Gallen JP: Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. J Rheumatol 17:122-125, 1990.
5. Krivanek JFC, Paver WKA: Further study of the use of dofazimine in discoid lupus erythematosus. Austral Asian J Dermatol 21:169-171, 1980.
6. Atra E, Sato EI: Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide. Clin Exp Rheumatol 11:487-493, 1993.
7. Dalziel K, Going G, Cartwright PH, et al: Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin). Br J Dermatol 115:211-216, 1986.
8. Rodriquez-Castellanos MA, Rubio JB, Gomez JFB, Mendoza AG: Phenytoin in the treatment of discoid lupus erythematosus. Arch Dermatol 131:620-621, 1995.
9. Nicolas JF, Thivolet J, Kanitkis J, Lyonnet S: Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a. J Invest Dermatol 95:142S-145S, 1990.
10. Prinz JC, Mearer M, Reiter C, et al: Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412. J Am Acad Dermatol 34:2440-2452, 1996.
11. Newton RC, Jorizzo JL, Solomon AR Jr, et al: Mechanism-oriented assessment of isotretinoin in chronic or subacute lupus erythematosus. Arch Dermatol 122:176-180, 1986